Escondido, CA, United States of America

Xenia Aparicio


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2021-2024

Loading Chart...
2 patents (USPTO):

Title: Xenia Aparicio: Innovator in Nucleic Acid Analysis

Introduction

Xenia Aparicio is a prominent inventor based in Escondido, California. She has made significant contributions to the field of nucleic acid analysis, holding 2 patents that showcase her innovative approach to scientific challenges. Her work focuses on developing advanced methods and apparatuses for sequencing nucleic acids, which are crucial for various applications in biotechnology and medicine.

Latest Patents

Aparicio's latest patents include "Temperature control for analysis of nucleic acids and other analytes" and "Methods and apparatuses for sequencing nucleic acids." The first patent describes an analytical detection apparatus that features a stage to support a flow cell, a detector to observe the detection channel, multiple fluid delivery channels connecting reservoirs to the detection channel, and a heater to maintain the temperature of the fluid delivery channels. These innovations are designed to enhance the accuracy and efficiency of nucleic acid analysis.

Career Highlights

Throughout her career, Xenia has worked with notable companies such as Pacific Biosciences of California, Inc. and Omniome, Inc. Her experience in these organizations has allowed her to refine her skills and contribute to groundbreaking advancements in the field of genetic analysis.

Collaborations

Xenia has collaborated with talented individuals in her field, including Michael John Erickstad and Eric Villarreal. These partnerships have fostered a creative environment that encourages the exchange of ideas and the development of innovative solutions.

Conclusion

Xenia Aparicio stands out as a dedicated inventor whose work in nucleic acid analysis is paving the way for future advancements in biotechnology. Her patents reflect her commitment to innovation and her ability to address complex scientific challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…